Atebimetinib
Product Specifications
CAS Number
2669009-92-9
Target
MEK
Related Pathways
MAPK
Purity
0.994
Bioactivity
Atebimetinib (IMM-1-104) is an orally active, deeply periodic MEK inhibitor that directly targets MEK and chronically suppresses MAPK signaling. It is intended for combination therapy in metastatic pancreatic cancer and non-small cell lung cancer (NSCLC) .
Smiles
O=C1OC=2C=C(OC(=O)N(C)C)C=CC2C(=C1CC=3C=CC=C(NS(=O)(=O)NC)C3F)CN(C)C
Molecular Formula
C23H27FN4O6S
Molecular Weight
506.55
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
142770-01 50 µg
Vascular Endothelial Growth Factor A (VEGFA) discontinued
Sign In for Pricing
View Details 142770-02 100 µg
Vascular Endothelial Growth Factor A (VEGFA) discontinued
Sign In for Pricing
View Details 